Published in

Wiley, International Journal of Cancer, 11(144), p. 2887-2896, 2019

DOI: 10.1002/ijc.32025

Links

Tools

Export citation

Search in Google Scholar

Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations

Journal article published in 2019 by Yen‐Ting Lin ORCID, Jin‐Shing Chen ORCID, Wei‐Yu Liao, Chao‐Chi Ho, Chia‐Lin Hsu, Ching‐Yao Yang, Kuan‐Yu Chen, Jih‐Hsiang Lee, Zhong‐Zhe Lin ORCID, Jin‐Yuan Shih, James Chih‐Hsin Yang, Chong‐Jen Yu ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO